Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Pharmacological inhibition of cFLIP targets breast cancer stem cells

French, Rhiannon, Hayward, Olivia, da Silva, Andreia Ribeiro, Robinson, Timothy, Seaton, Gillian and Clarkson, Richard ORCID: https://orcid.org/0000-0001-7389-8673 2025. Pharmacological inhibition of cFLIP targets breast cancer stem cells. Journal of Cancer Treatment and Diagnosis 8 (2) 10.29245/2578-2967/2025/2.1210

[thumbnail of pharmacological-inhibition-of-cflip-targets-breast-cancer-stem-cells.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (1MB)

Abstract

Therapeutic targeting of tumour initiating, cancer stem cells (CSCs), offers the potential to improve long-term responses to cancer treatments. The apoptosis related protein Cellular FLICE-Like Inhibitory Protein (cFLIP) has previously been reported to protect breast cancer cells and breast CSCs from the cytotoxic effects of chemotherapy and apoptosis-inducing agents. We recently described the development of a small-molecule protein-protein inhibitor of cFLIP (OH14) that sensitizes refractory breast cancer cells to the death-receptor agonist Tumour Necrosis Factor Alpha Receptor Apoptosis Inducing Ligand (TRAIL). Here we investigated whether the pharmacological inhibition of cFLIP also targeted breast CSCs. Human breast cancer cell lines and primary-derived breast cancer samples were subjected to OH14 with or without TRAIL and assessed for bCSC viability by colony-formation and tumoursphere assay in vitro and xenograft tumour initiation in vivo. OH14 potentiated a reduction in the number of bCSCs after TRAIL treatment, mimicking the sensitizing effects previously observed with epigenetic silencing of cFLIP. Moreover, prolonged inhibition of cFLIP alone, either by shRNA knockdown or treatment with OH14, reduced the bCSC pool, an outcome that was independent of caspases. These data provide proof-of-principle for the use of pharmacological inhibitors of cFLIP to target bCSCs and highlights for the first time both apoptosis-dependent and independent mechanisms for cFLIP-mediated regulation of the breast cancer stem cell pool.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Biosciences
ISSN: 2578-2967
Date of First Compliant Deposit: 22 October 2025
Date of Acceptance: 8 August 2025
Last Modified: 24 Oct 2025 11:00
URI: https://orca.cardiff.ac.uk/id/eprint/181842

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics